Koga, T., Sumiyoshi, R., Tsuji, Y., Kodama, K., Endo, Y., Furukawa, K., & Kawakami, A. (2023). Efficacy and safety of 5-aminolevulinic acid in adult-onset Still's disease: A preclinical study in mice and a pilot study in humans. Clinical immunology (Orlando, Fla.), 257, 109846. https://doi.org/10.1016/j.clim.2023.109846
Style de citation ChicagoKoga, Tomohiro, Remi Sumiyoshi, Yoshika Tsuji, Ken Kodama, Yushiro Endo, Kaori Furukawa, et Atsushi Kawakami. "Efficacy and Safety of 5-aminolevulinic Acid in Adult-onset Still's Disease: A Preclinical Study in Mice and a Pilot Study in Humans." Clinical Immunology (Orlando, Fla.) 257 (2023): 109846. https://dx.doi.org/10.1016/j.clim.2023.109846.
Style de citation MLAKoga, Tomohiro, et al. "Efficacy and Safety of 5-aminolevulinic Acid in Adult-onset Still's Disease: A Preclinical Study in Mice and a Pilot Study in Humans." Clinical Immunology (Orlando, Fla.), vol. 257, 2023, p. 109846.